ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
2,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,Y
3,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
4,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,Y
6,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
6,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
7,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7,2,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
7,3,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
8,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
8,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
9,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
9,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
10,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10,2,Mental disorder due to a general medical condition,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
11,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
11,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
11,5,Puncture site haemorrhage,Administration site reactions NEC,Administration site reactions,Genrl,N
11,6,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
12,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
13,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,2,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
13,3,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
14,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
15,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
15,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
16,1,Puncture site haemorrhage,Administration site reactions NEC,Administration site reactions,Genrl,N
17,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
18,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
19,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,Y
20,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
20,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
20,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
20,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
20,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,6,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
21,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
22,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
22,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
23,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
23,2,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
24,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
25,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
26,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
27,1,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
27,2,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
28,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
28,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
29,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
30,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
30,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
31,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
31,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
32,2,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
32,3,Vascular stent thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
33,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
34,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
35,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
36,1,Catheter site haemorrhage,Implant and catheter site reactions,Administration site reactions,Genrl,N
37,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
37,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
37,3,Vascular stent thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
38,1,Catheter site haemorrhage,Implant and catheter site reactions,Administration site reactions,Genrl,N
38,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
39,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
40,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
41,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,Y
41,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
41,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
42,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
43,1,Coagulation time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
43,2,Device related thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
44,1,Vascular stent thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
45,1,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
46,1,Vascular stent thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
47,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
47,2,Contraindication to medical treatment,Social issues NEC,Lifestyle issues,SocCi,N
48,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
48,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
49,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
50,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
51,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
51,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
